Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendrimers in Alzheimer’s Disease: Recent Approaches in Multi-Targeting Strategies
Cécile Arbez‐Gindre, Barry R. Steele, Maria Micha‐Screttas
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 898-898
Open Access | Times Cited: 19

Showing 19 citing articles:

Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management
Jinjin Pei, Ranil Vikraman Kumarasamy, Selvaraj Jayaraman, et al.
Ageing Research Reviews (2025), pp. 102665-102665
Closed Access | Times Cited: 8
Biomaterials Comprising Implantable and Dermal Drug Delivery Targeting Brain in Management of Alzheimer’s Disease: A Review
Neelakanta Sarvashiva Kiran, Gorthi Vaishnavi, Sudarshan Singh, et al.
Regenerative Engineering and Translational Medicine (2024)
Closed Access | Times Cited: 6
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Latest Perspectives on Alzheimer’s Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems
Bianca Sânziana Daraban, A Popa, Miruna S. Stan
Molecules (2024) Vol. 29, Iss. 17, pp. 4056-4056
Open Access | Times Cited: 6
Breaking the barriers in management of Alzheimer's disease through cationic nanoformulation: A review
Abhijeet Puri, Popat Mohite, Showkhiya Khan, et al.
Results in Chemistry (2024) Vol. 7, pp. 101463-101463
Open Access | Times Cited: 4
Advancing brain immunotherapy through functional nanomaterials
Bhanu Nirosha Yalamandala, Thi My Hue Huynh, Hui-Wen Lien, et al.
Drug Delivery and Translational Research (2025)
Open Access
Nano lipid-drug conjugates for the treatment of Alzheimer’s disease
Subhajit Mandal, Malay K. Das
Elsevier eBooks (2025), pp. 237-291
Closed Access
Dendrimers—Novel Therapeutic Approaches for Alzheimer’s Disease
Magdalena Mroziak, Gracjan Kozłowski, Weronika Kołodziejczyk, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1899-1899
Open Access | Times Cited: 2
A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer’s
Vaibhav Rastogi, Anjali Jain, Prashant Kumar, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 7, pp. 725-744
Closed Access | Times Cited: 4
Dendrimers for Drug Delivery: Where Do We Stand in 2023?
Evgeny Apartsin
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2740-2740
Open Access | Times Cited: 4
Medicinal chemistry-based novel herapeutics for Tauopathies in Alzheimer’s disease
Subashchandrabose Chinnathambi, Sneha Malik, Madhura Chandarshekar, et al.
Advances in protein chemistry and structural biology (2024)
Closed Access | Times Cited: 1
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
Meixiang Huang, Carolyn Tallon, Xiaolei Zhu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2364-2364
Open Access | Times Cited: 2
Functionalization of Carbon-Based Nanoparticles for Various Applications
Shweta Sharma, Vijay Laxmi Tripathi, Versha Dixit, et al.
(2024), pp. 59-81
Closed Access
1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization
Rotimi Sheyi, Jessica T. Mhlongo, Marta Jorba, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5883-5883
Open Access
Pharmacokinetic Assessments of Ursolic Loaded-Dendrimer Complex
Aditya Singh, Valeed Ahmad Ansari, Tarique Mahmood, et al.
Current Pharmaceutical Analysis (2024) Vol. 20, Iss. 7, pp. 538-556
Closed Access
Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease
M.P.S. Negi, Etikala Amulya, Vivek Phatale, et al.
Life Sciences (2024) Vol. 358, pp. 123155-123155
Closed Access
Design of reversible cholinesterase inhibitors: Fine-tuning of enzymatic activity by PAMAM-calix-dendrimers
Igor Shiabiev, Dmitry Pysin, Alexandra Kharlamova, et al.
International Journal of Biological Macromolecules (2024), pp. 138503-138503
Closed Access
Neuro-Nanocarriers: Redefining Treatment Pathways for Brain Disorders
Advaita Chauhan, Dhaval Mori, Moinuddin Soniwala, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access
Upcoming Nano and Conventional Drug Delivery Strategies for Alzheimer’s Disease
Nila Mary Varghese, Nandhakumar Sathyamoorthy, Praveen Thaggikuppe Krishnamurthy, et al.
(2024), pp. 313-332
Closed Access
Page 1

Scroll to top